The Influence of Cyclic Hormonal Contraception on Expression of Premenstrual Syndrome

Journal of Women's Health

Volumn 26, Issue 4, 2017, Pages 321-328

  Yonkers, Kimberly A ^a   Cameron, Brianna ^b   Gueorguieva, Ralitza ^b   Altemus, Margaret ^a   Kornstein, Susan G ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contraception; menstrual cycle; mental health

Indexed keywords

ADULT; ANGER; ARTICLE; BREAST DISEASE; CONCENTRATION LOSS; CONTROLLED STUDY; DEPRESSION; FEMALE; HEADACHE; HORMONAL CONTRACEPTION; HUMAN; INCREASED APPETITE; IRRITABILITY; LETHARGY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION; MOOD DISORDER; MYALGIA; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP DISORDER; ADOLESCENT; BODY WEIGHT; CHEMICALLY INDUCED; CONTRACEPTION; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ANGER; BODY WEIGHT; CONTRACEPTION; CONTRACEPTIVES, ORAL, HORMONAL; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; MOOD DISORDERS; PREMENSTRUAL SYNDROME; YOUNG ADULT;

EID: 85018463295     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2016.5941     Document Type: Article

References (27)

1. ACOG. ACOG issues guidelines on diagnosis and treatment of PMS. 2003. www.acog.org/patients/FAQs/premenstrualsyndrome-PMS Accessed May 1, 2015.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.
3. Hurt SW, Schnurr PP, Severino SK, et al. Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints. Am J Psychiatry 1992;149:525-530.
4. Hartlage SA, Arduino KE. Toward the content validity of premenstrual dysphoric disorder: Do anger and irritability more than depressed mood represent treatment seekers experiences? Psychol Rep 2002;90:189-202.
5. Epperson CN, Steiner M, Hartlage SA, et al. Premenstrual dysphoric disorder: Evidence for a new category for DSM-5 Am J Psychiatry 2012;169:465-475.
6. Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 2005;106:492-501.
7. Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 2005;72:414-421.
8. Halbreich U, Freeman EW, Rapkin AJ, et al. Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder. Contraception 2012;85:19-27.
9. Backstrom T, Hansson-Malmstrom Y, Lindhe B-A, Cavalli-Bjorkman B, Nordenstrom S. Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparations. Contraception 1992;46: 253-268.
10. Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992;36:257-266.
11. Freeman EW. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder. Eur J Contracept Reprod Health Care 2002;7:27-34.
12. O'Brien PMS, Backstrom T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: The ISPMD Montreal consensus. Arch Womens Ment Health 2011;14:13-21.
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Association; 1994.
14. Abraham SS. Oral contraception and cyclic changes in premenstrual and menstrual experiences. J Psychosom Obstet Gynaecol 2003;24:185-193.
15. Andersch B, Hahn L. Premenstrual complaints II. Influence of oral contraceptives. Acta Obstet Gynecol Scand 1981;60: 579-583.
16. Boyle GJ, Grant AF. Prospective versus retrospective assessment of menstrual cycle symptoms and moods: Role of attitudes and beliefs. J Psychopathol Behav Assess 1992; 14:307-321.
17. Marriott A, Faragher EB. An assessment of psychological state associated with the menstrual cycle in users of oral contraception. J Psychosom Res 1986;30:41-47.
18. Paige KE. Effects of oral contraceptives on affective fluctuations associated with the menstrual cycle. Psychosom Med 1971;33:515-537.
19. Ross C, Coleman G, Stojanovska C. Factor structure of the modified Moos Menstrual Distress Questionnaire: Assessment of prospectively reported follicular, menstrual and premenstrual symptomatology. J Psychosom Obstet Gynecol 2003;24:163-174.
20. Sveinsdottir H, Backstrom T. Menstrual cycle symptom variation in a community sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand 2000;79:757-764.
21. Wilcoxon LA, Schrader SL, Sherif CW. Daily self-reports on activities, life events, moods, and somatic changes during the menstrual cycle. Psychosom Med 1976;38:399-417.
22. Walker A, Bancroft J. Relationship between premenstrual symptoms and oral contraceptive use: A controlled study. Psychosom Med 1990;52:86-96.
23. Yonkers KA, Kornstein SG, Gueorguieva R, Merry B, Van Steenburgh K, Altemus M. Symptom-onset dosing of sertraline for the treatment of premenstrual dysphoric disorder: A randomized clinical trial. JAMA Psychiatry 2015;72: 1037-1044.
24. Hartlage SA, Freels S, Gotman N, Yonkers K. Criteria for premenstrual dysphoric disorder: Secondary analyses of relevant data sets. Arch Gen Psychiatry 2012;69:300-305.
25. Schnurr PP. Measuring amount of symptom change in the diagnosis of premenstrual syndrome. Psycholog Assess 1989;1:277-283.
26. Warner P, Bancroft J. Mood, sexuality, oral contraceptives and the menstrual cycle. J Psychosom Res 1988;32:417-427.
27. Wittchen H, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002;32:119-132.